Plunkett Research Online: Acorda Therapeutics Inc

ACORDA THERAPEUTICS INC (ACOR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes,.....



Acorda Therapeutics Inc
Ticker: ACOR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 914-347-4300
Fax: 914-347-4560
Address: 2 Blue Hill Plaza
3rd Floor, Pearl River
New York, NY 10965 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Biopharmaceutical Development
Contacts Description
Ron CohenCEO/Director/Founder/President
Michael GesserCFO/Chief Accounting Officer/Treasurer
See More
Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes,.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Inbrija
Ampyra
Fampyra
GGFS
rHIgM22
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: